Cerebrospinal Fluid Biomarkers for the Diagnosis of Prodromal Alzheimer's Disease in Amnestic Mild Cognitive Impairment

BACKGROUND/AIMS: Disease-modifying therapy for Alzheimer's disease (AD) has led to a need for biomarkers to identify prodromal AD and very early stage of AD dementia. We aimed to identify the cutoff values of cerebrospinal fluid (CSF) biomarkers for detecting prodromal AD. METHODS: We assessed...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Jung Eun, Choi, Kyu Yeong, Kim, Byeong C., Choi, Seong-Min, Song, Min-Kyung, Lee, Jang Jae, Kim, Jahae, Song, Ho-Chun, Kim, Hoo-Won, Ha, Jung-Min, Seo, Eun Hyun, Song, Woo Keun, Park, Sung-Gyoo, Lee, Jung Sup, Lee, Kun Ho
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2019
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6465729/
https://www.ncbi.nlm.nih.gov/pubmed/31011328
http://dx.doi.org/10.1159/000496920

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6465729/
https://www.ncbi.nlm.nih.gov/pubmed/31011328
http://dx.doi.org/10.1159/000496920

Ejemplares similares